Neurocardiogenic syncope in children with a normal heart

South Carolina Children's Heart Center, Division of Pediatric Cardiology, Medical University of South Carolina, Charleston.

OBJECTIVES. The purpose of this study was to review the results of investigation and management of children with syncope and a structurally normal heart. BACKGROUND. Syncope is a common clinical problem and has many etiologies. Autonomic testing and, in particular, the tilt/orthostatic test have helped to positively diagnose neurocardiogenic syncope in a high proportion of such patients. METHODS. Patient case notes and autonomic test charts were reviewed in 162 children aged 1 to 20 years (mean age 12.8 years) with syncope. The autonomic test consisted of orthostatic maneuver, carotid sinus massage, diving reflex, Valsalva maneuver and dose response to intravenous boluses of isoproterenol and phenylephrine. Serum levels of epinephrine and norepinephrine were drawn during the orthostatic test. After confirmation of neurocardiogenic syncope, treatment was begun with fludrocortisone and salt, and beta-adrenergic blocking agents were used as a second line of therapy when indicated. RESULTS. The orthostatic test was positive for neurocardiogenic syncope in 100 patients (62%) and negative in 62 (38%). Patients in the former group were older, were more often female and had a diminished response to carotid sinus massage, a higher Valsalva ratio and a higher supine epinephrine level. Both groups showed an increase in epinephrine and norepinephrine levels at 5 min of standing. In the orthostatic positive group at the time of syncope, norepinephrine levels decreased, whereas epinephrine levels increased. Patients in this group were also more sensitive to the vasodilating effect of isoproterenol but not to its chronotropic effects. Eleven patients had cardioinhibitory syncope (asystole > or = 3 s). Of these, three had pacemaker implantation. Fludrocortisone and salt used in 84 patients in the orthostatic positive group produced resolution of symptoms in 55 patients (65%) and improvement in 14 (17%). Ten patients received beta-blockers, with resolution in four and improvement in four. CONCLUSIONS. Patients with orthostatic test-proved neurocardiogenic syncope show evidence of autonomic dysfunction. They also show beta-adrenergic hypersensitivity. Treatment initiated on the basis of the protocol was associated with amelioration of symptoms in the majority of patients.

This article has been cited by other articles:

				A. P. Vlahos, M. Tzoufi, C. S. Katsouras, T. Barka, I. Sionti, L. K. Michalis, A. Siamopoulou, and T. M. Kolettis Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin Pediatrics, February 1, 2007; 119(2): e419 - e425. [Abstract] [Full Text] [PDF]

				R. Sheldon, S. Connolly, S. Rose, T. Klingenheben, A. Krahn, C. Morillo, M. Talajic, T. Ku, F. Fouad-Tarazi, D. Ritchie, et al. Prevention of Syncope Trial (POST): A Randomized, Placebo-Controlled Study of Metoprolol in the Prevention of Vasovagal Syncope Circulation, March 7, 2006; 113(9): 1164 - 1170. [Abstract] [Full Text] [PDF]

				M. A. Salim and T. G. Di Sessa Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: A double-blind, placebo-controlled, randomized trial J. Am. Coll. Cardiol., February 15, 2005; 45(4): 484 - 488. [Abstract] [Full Text] [PDF]

				P. Alboni, M. Dinelli, P. Gruppillo, M. Bondanelli, K. Bettiol, P. Marchi, and E. C. d. Uberti Haemodynamic changes early in prodromal symptoms of vasovagal syncope Europace, January 1, 2002; 4(3): 333 - 338. [Abstract] [PDF]

				C.M. Seifer and R.A. Kenny Head-up tilt testing in children Eur. Heart J., November 1, 2001; 22(21): 1968 - 1971. [PDF]

				C. Kouakam, G. Vaksmann, E. Pachy, D. Lacroix, C. Rey, and S. Kacet Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence Eur. Heart J., September 1, 2001; 22(17): 1618 - 1625. [Abstract] [PDF]

				P. C. Rowe, H. Calkins, K. DeBusk, R. McKenzie, R. Anand, G. Sharma, B. A. Cuccherini, N. Soto, P. Hohman, S. Snader, et al. Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue Syndrome: A Randomized Controlled Trial JAMA, January 3, 2001; 285(1): 52 - 59. [Abstract] [Full Text] [PDF]

				S. Ritter, L. Y. Tani, S. P. Etheridge, R. V. Williams, J. E. Craig, and L. L. Minich What Is the Yield of Screening Echocardiography in Pediatric Syncope? Pediatrics, May 1, 2000; 105(5): 58e - 58. [Abstract] [Full Text]

				P. Alboni, M. Bondanelli, M. Dinelli, P. Gruppillo, P. Franceschetti, P. Marchi, and E.C. degli Uberti Role of the serotonergic system in the genesis of vasovagal syncope Europace, January 1, 2000; 2(2): 172 - 180. [Abstract] [PDF]

				T. R. Burklow, J. P. Moak, J. J. Bailey, and F. T. Makhlouf Neurally mediated cardiac syncope: autonomic modulation after normal saline infusion J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2059 - 2066. [Abstract] [Full Text] [PDF]

				J. M. Stewart, M. H. Gewitz, A. Weldon, N. Arlievsky, K. Li, and J. Munoz Orthostatic Intolerance in Adolescent Chronic Fatigue Syndrome Pediatrics, January 1, 1999; 103(1): 116 - 121. [Abstract] [Full Text] [PDF]

				M. A. Salim, L. E. Ware, M. Barnard, B. S. Alpert, and T. G. DiSessa Syncope Recurrence in Children: Relation to Tilt-test Results Pediatrics, October 1, 1998; 102(4): 924 - 926. [Abstract] [Full Text] [PDF]